Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: An analysis of four alliance clinical trials.


33 Background: Pathologic complete response (pCR) is an important prognostic indicator and surrogate endpoint, particularly for patients with hormone receptor-negative breast cancer. Previous studies have suggested differential response to pre-operative therapy by age and body mass index (BMI), though no association has been seen by race. We assessed… (More)
DOI: 10.1200/jco.2015.33.28_suppl.33


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics